Shamburg News · 8-K filed Nov 10, 2026, 4:43 PM EST
KORU Medical Reports Q3 2026 Results and Raises Year-End Cash Guidance
KRMD · KORU Medical Systems, Inc.
- Earnings
- Materiality: high
On November 10, 2026, KORU Medical Systems, Inc. reported third quarter 2026 results, with net revenues of $11,566,555 (up 11.2%) and net income of $218,103, or $0.00 per diluted share. Adjusted EBITDA was $1,313,257, or $0.02 per adjusted diluted share. The company revised full-year 2026 revenue guidance to $48.0 - $48.5 million, narrowed gross margin guidance to 63% - 64%, and raised its year-end cash balance guidance to greater than $8.0 million.
Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001161697-26-000243.
Written from the filing by Shamburg Markets. Figures are as reported by the company.